ロード中...
Levodopa—carbidopa intestinal gel in advanced Parkinson’s disease open-label study: Interim results
Levodopa–carbidopa intestinal gel (LCIG) delivered continuously via percutaneous endoscopic gastrojejunostomy (PEG-J) tube has been reported, mainly in small open-label studies, to significantly alleviate motor complications in Parkinson’s disease (PD). A prospective open-label, 54-week, internation...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3661282/ https://ncbi.nlm.nih.gov/pubmed/23287001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2012.11.020 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|